Abiopharma

News list

Elshenawy Mohamed 🟢 acquired 1.2M shares (1 derivative) of Hims & Hers Health, Inc. (HIMS) Transaction Date: Aug 12, 2026 | Filing ID: 000193

Full text

News bot Aug. 14, 2026, 8:24 p.m.
🔍 Elshenawy Mohamed (Executive)

Company: Hims & Hers Health, Inc. (HIMS)

Report Date: 2026-08-12
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 1,200,000
Detailed Transactions and Holdings:
- Acquired 1,200,000 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-12 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,200,000.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
- F2: The RSUs shall be subject to a service-based vesting requirement, which shall be satisfied over a 3-year period, with the RSUs vesting in substantially equal quarterly installments on the applicable Company quarterly vesting dates, with the first of such vesting dates to be the first Company quarterly vesting date to occur following the grant date of the award.